User profiles for M. Mannis

Mark Mannis

University of California, Davis, Dept of Ophthalmology & Vision Science
Verified email at ucdavis.edu
Cited by 13988

Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee

…, RD Granstein, S Kang, M Mannis, M Steinhoff… - Journal of the American …, 2018 - Elsevier
In 2002, the National Rosacea Society assembled an expert committee to develop the first
standard classification of rosacea. This original classification was intended to be updated as …

The IC3D classification of the corneal dystrophies

…, FL Munier, B Seitz, J Sutphin, C Bredrup, MJ Mannis… - Cornea, 2008 - journals.lww.com
Background: The recent availability of genetic analyses has demonstrated the shortcomings
of the current phenotypic method of corneal dystrophy classification. Abnormalities in …

Contact lenses in the management of keratoconus

M Barnett, MJ Mannis - Cornea, 2011 - journals.lww.com
The range of contact lens modalities currently available for the successful optical correction
of keratoconus is greatly expanded. We review lens types currently available for the …

[BOOK][B] Cornea e-book

JH Krachmer, MJ Mannis, EJ Holland - 2010 - books.google.com
Cornea, edited by Drs. Krachmer, Mannis & Holland, is the only truly comprehensive clinical
reference available that covers external disease, anterior uveitis, and the expanding range …

Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel

…, M Mannis, HH Oon, M Rajagopalan… - British journal of …, 2017 - academic.oup.com
Background Rosacea is currently diagnosed by consensus‐defined primary and secondary
features and managed by subtype. However, individual features (phenotypes) can span …

Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel

…, M Mannis, HH Oon, M Rajagopalan… - British Journal of …, 2017 - academic.oup.com
Background Rosacea is currently treated according to subtypes. As this does not adequately
address the spectrum of clinical presentation (phenotypes), it has implications for patient …

Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea

…, K Ofuji, TW Reid, MJ Mannis… - Journal of cellular …, 1996 - Wiley Online Library
We find that substance P (SP) and insulin‐like growth factor‐1 (IGF‐1) demonstrate a
synergistic effect on the stimulation of rabbit corneal epithelial migration in an organ culture. The …

Intraocular lens power calculation after laser in situ keratomileusis for myopia and hyperopia: a standardized approach

V Feiz, MJ Mannis, F Garcia-Ferrer, G Kandavel… - Cornea, 2001 - journals.lww.com
Purpose. (1) To determine the effect of myopic and hyperopic laser in situ keratomileusis (LASIK)
on calculation of intraocular lens (IOL) power.(2) To determine a standard way to …

Defensins are mitogenic for epithelial cells and fibroblasts

CJ Murphy, BA Foster, MJ Mannis… - Journal of cellular …, 1993 - Wiley Online Library
… The leukocytes were resuspended in 0.34 M sucrose (pH 7.4) and homogenized in a glass
teflon pestle homogenizer. Cell debris and unbroken cells were removed by another low-…

Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis

MA Greiner, JY Li, MJ Mannis - Ophthalmology, 2011 - Elsevier
PURPOSE: To evaluate retention of visual acuity and development of complications after
Boston type 1 keratoprosthesis implantation over a longer follow-up period than previously …